Helicobacter pylori infection in Neuromyelitis Optica and Multiple Sclerosis

Youming Long1, Cong Gao, Wei Qiu

  • 1Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and Ministry of Education of China, Institute of Neuroscience, and Department of Neurology, Second Affiliated Hospital of GuangZhou Medical University, Guangzhou, People's Republic of China.

Neuroimmunomodulation
|January 9, 2013
PubMed
Abstract

Insights

Helicobacter pylori infection is common in patients with Neuromyelitis Optica (NMO) spectrum disorders and may be a risk factor. This study investigated H. pylori status in NMO and Multiple Sclerosis (MS) patients.

Area of Science:

  • Neuroimmunology
  • Infectious Diseases
  • Microbiology

Background:

  • Neuromyelitis Optica (NMO) spectrum disorders and Multiple Sclerosis (MS) are inflammatory demyelinating diseases of the central nervous system.
  • The role of infectious agents, such as Helicobacter pylori (H. pylori), in the pathogenesis of these conditions is under investigation.

Purpose of the Study:

  • To investigate the prevalence of H. pylori infection in patients diagnosed with NMO spectrum disorders and MS.
  • To explore the potential association between H. pylori seropositivity and these neurological conditions, including the presence of Aquaporin-4 (AQP4) antibodies.

Main Methods:

  • H. pylori infection status was determined using an indirect immunofluorescence assay.
  • Aquaporin-4 (AQP4) antibody detection was performed via a cell-based assay.
  • Seroprevalence of H. pylori was assessed in patients with NMO, high-risk NMO (hrNMO), MS, and healthy controls, followed by logistic regression analysis.

Main Results:

  • A high prevalence of H. pylori antibodies was observed across all groups, with seropositivity rates of 90.4% in NMO, 95.8% in hrNMO, 73.8% in MS, and 59.3% in controls.
  • NMO spectrum patients exhibited significantly higher H. pylori positivity compared to MS patients and controls (p < 0.05).
  • H. pylori seropositivity was significantly associated with hrNMO (OR = 9.311, p = 0.005) and the combined hrNMO + NMO group (OR = 6.350, p = 0.028).

Conclusions:

  • Helicobacter pylori infection is highly prevalent in Chinese patients with NMO and hrNMO.
  • H. pylori infection may represent a potential risk factor contributing to the development of the NMO spectrum disorders.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...